Search

New findings may stimulate the development of targeted therapies for proptosis in patients with acute thyroid eye disease Boston, Mass. — Researchers from Mass. Eye and Ear - including Schepens Eye Research Institute - and Boston Children's Hospital have identified new underlying mechanisms of...

The strategic licensing agreement between Lonza and Massachusetts Eye and Ear® underscores Lonza’s position as a leading AAV manufacturing service provider and offers customers unprecedented technology and services to commercialize next generation gene therapies. The Anc-AAV vector platform has the...

Attracting more than 330 alumni, faculty, and trainees, the 2016 HMS Ophthalmology Annual Meeting and Alumni Reunion offered an array of continuing medical education (CME) events as well as opportunities for networking and reconnecting with classmates. Most attendees were from the New England and...

Demetrios Vavvas, MD, PhD, Pawan Sinha, PhD, Michael Young, PhD, and Joan W. Miller, MD, FARVO The first Symposium on Ocular Regeneration: Cell Therapy and Regeneration in the Retina, held on October 23, 2014, drew over 150 participants from the United States and abroad. Co-chaired by Michael Young...

Faculty Recognition Joseph Arboleda-Velasquez, MD, PhD, received a grant from the National Institute of Neurological Disorders and Stroke and National Institute of Aging/National Institutes of Health in the amount of $1,016,301 over five years for his project, "Exploring the Role of Aging in...

Congratulations to Harvard Ophthalmology faculty who were recognized as one of “ Boston’s Top Doctors 2016,” by Boston Magazine and/or were named in 2016 as a “ Top Ophthalmologists in Boston ,” by Castle Connolly .

Upneet Bains, MD, has been named the 2016-2017 Ruthanne and Richard Simmons Glaucoma Fellow in the Harvard Medical School Department of Ophthalmology. This annual award was established in 2011 in recognition of two glaucoma physicians who were Harvard Ophthalmology graduates: the late Dr. Ruthanne...

Treating donor tissue with a special cocktail of molecules improves outcomes and promotes survival of high-risk corneal transplants Boston, Mass. — Treating donor corneas with a cocktail of molecules prior to transplanting to a host may improve survival of grafts and, thus, outcomes in high-risk...

State-of-the-art high-definition, platform aims to bring care of adult and pediatric patients to an unprecedented level Boston, Mass. — Massachusetts Eye and Ear is enhancing the care it brings to adult and pediatric retina patients with a new and innovative vitreoretinal surgical platform, known as...

Dean Eliott, MD, received the Lifetime Mentorship Award from the Vit-Buckle Society at their 5 th Annual Meeting in April. The Vit-Buckle Society provides an open forum that mentors developing vitreoretinal surgeons, nurtures innovative surgical technologies and therapeutic approaches for retinal...